DLX Transcription Factors for Multilineage Neural Regeneration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current technologies are unable to achieve multilineage reprogramming of resident glial cells, which is essential for neural regeneration and regenerative medicine, as they only induce the generation of new neurons without producing all three necessary cell types: neurons, astrocytes, and oligodendrocytes.
Innovation Solution
The use of viral vectors carrying polynucleotide sequences encoding DLX family transcription factors, specifically DLX2, operably linked to glial cell targeting promoters, to induce multilineage differentiation and neural regeneration by reprogramming glial cells into neural progenitor cells that can give rise to all three cell types.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If viral vectors carrying DLX family transcription factors are used to induce neuron generation, then new neurons are produced, but all three necessary cell types (neurons, astrocytes, and oligodendrocytes) are not generated
Solution Approach 1:
The patent changes the molecular parameters by introducing specific transcription factors (DLX1, DLX2, DLX5, or DLX6) to alter the differentiation trajectory of glial cells. This parameter change enables the cells to generate all three neural lineages (neurons, astrocytes, and oligodendrocytes) rather than just neurons, thereby resolving the contradiction between productivity in neuron generation and adaptability for multilineage differentiation.
2Ease of operation
If fate reprogramming is accomplished through controlling expression of fate-determining factors, then new neurons are generated from resident glia, but multilineage reprogramming to produce all three cell types is not achieved
Solution Approach 1:
The patent applies universality by using a single set of transcription factors (DLX family) that can drive multiple differentiation outcomes. These factors enable resident glial cells to universally generate all three neural cell types (neurons, astrocytes, and oligodendrocytes) across different brain regions, achieving multilineage reprogramming capability while maintaining ease of operation through controlled expression of these key determinants.
Data Source
AI summary
Provided are compositions comprising DLX family transcription factors, and methods for their use for neural regeneration. The compositions can be widely used in regenerative medicine to repair neural injuries or degeneration and improve cell plasticity.